News - Vitaros

Filter

Current filters:

Vitaros

Popular Filters

Apricus expands Vitaros deal with Novartis unit

Apricus expands Vitaros deal with Novartis unit

16-12-2013

USA-based Apricus Biosciences has expanded its exclusive license agreement with Hexal AG, an affiliate…

Apricus BioscienceEuropeLicensingMen's HealthNovartisPharmaceuticalSandozVitaros

Apricus ED drug gains national phase approval in Germany

09-10-2013

Germany's Federal Institute for Drugs and Medical Devices has granted national phase approval for USA-based…

Apricus BioscienceEuropeMen's HealthPharmaceuticalRegulationSandozVitaros

Swiss regulator stalls approval of Apricus Biosciences' Vitaros

02-09-2013

USA-based Apricus Biosciences (Nasdaq: APRI) says that Swissmedic, the Agency for Therapeutic Products…

Apricus BioscienceEuropeMen's HealthPharmaceuticalRegulationVitaros

Apricus Biosciences gains two more approvals for ED drug Vitaros

15-08-2013

USA-based Apricus Biosciences (Nasdaq: APRI) says that the Irish Medicines Board and the Netherlands'…

Apricus BioscienceEuropeMen's HealthPharmaceuticalRegulationReproductiveVitaros

Apricus to stop funding French units; will focus on Vitaros and Femprox

14-03-2013

USA-based Apricus Biosciences (Nasdaq: APRI) says that it intends to cease financing its French subsidiaries,…

Apricus BioscienceEuropeFemproxFinancialNexMed PharmaPharmaceuticalResearchScomedicaVitaros

Apricus collaborates with Sandoz for ED drug

17-02-2012

San Diego, USA-based Apricus Biosciences (Nasdaq: APRI) said yesterday that its wholly-owned subsidiary…

Apricus BioscienceEuropeLicensingMen's HealthNovartisPharmaceuticalReproductiveSandozVitaros

Apricus Biosciences to file for topical ED drug Vitaros in Latin America

10-08-2011

San Diego, USA-based Apricus Biosciences (Nasdaq: APRI) says that it will file for market authorization…

AlprostadilApricus BiosciencePharmaceuticalRegulationReproductiveSouth AmericaVitaros

Back to top